M&A Deal Summary

Boston Scientific Acquires InFlow Dynamics

On February 12, 2002, Boston Scientific acquired medical products company InFlow Dynamics from Endurance Capital AG

Acquisition Highlights
  • This is Boston Scientific’s 4th transaction in the Medical Products sector.
  • This is Boston Scientific’s 1st transaction in Germany.

M&A Deal Summary
Date 2002-02-12
Target InFlow Dynamics
Sector Medical Products
Buyer(s) Boston Scientific
Sellers(s) Endurance Capital AG
Deal Type Add-on Acquisition

Target

InFlow Dynamics

Munich, Germany
website
InFlow Dynamics Ltd. produces and distributes coronary stent systems for removing arterial constriction.

Search 193,502 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website

Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 5 of 62
Sector (Medical Products) 4 of 48
Type (Add-on Acquisition) 5 of 48
Country (Germany) 1 of 2
Year (2002) 1 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2001-06-30 Cardiac Pathways

Sunnyvale, California, United States

Cardiac Pathways Corp. a maker of systems for diagnosing irregular heartbeats.

Buy $115M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2002-06-13 Enteric Medical Technologies

Foster City, California, United States

Enteric Medical Technologies, Inc. is a medical device company focused on developing an FDA-approved polymer injection for the treatment of gastroesophageal reflux disease (GERD).

Buy -

Seller(S) 1

SELLER

Endurance Capital AG

Munich, Germany

Investor Investor Investor

website

Category Private Equity Firm
Size Small
Type Sector Agnostic
DESCRIPTION

Endurance Capital AG is a private investment firm focused on a variety of transaction situations in Germany, Switzerland, and Austria. Endurance targets divestitures, special situations, as well as companies facing shareholder disputes or succession issues. Sectors of interest include automotive, engineering, fashion/textiles, and retail. Endurance seeks to invest a up to €20 million in businesses generating €20 to €300 million of annual revenue. Endurance Capital AG is based in Munich.

DEAL STATS #
Overall 1 of 3
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 3
Country (Germany) 1 of 3
Year (2002) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-10-12 gate5

Berlin, Germany

gate5 was a software company based in Berlin and developed solutions for mobile navigation on PDAs and Smartphones.

Sell -
Mergr

Product

Company

Legal